CD137 binding fibronectin type III domains

BACILLUS THURINGIENSIS TOXIN RECEPTORS AND USES THEREOF

FORMULATION CONTAINING TLR AGONIST AND METHODS OF USE

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

KNOCKDOWN OR KNOCKOUT OF ONE OR MORE OF TAP2, NLRC5, B2m, TRAC, RFX5, RFXAP and RFXANK TO MITIGATE T CELL RECOGNITION OF ALLOGENEIC CELL PRODUCTS

Engineered platelets for targeted delivery of a therapeutic agent

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF B-SARCOGLYCAN AND MICRORNA-29 AND THE TREATMENT OF MUSCULAR DYSTROPHY

Peptides and combination of peptides for use in immunotherapy against various cancers

A NOVEL THERAPY FOR ERYTHROPOIETIC PROTOPORPHYRIA (EPP) AND X-LINKED PROTOPORPHYRIA (XLP)

METHODS OF TREATING CANCER

ALK4:actriib heteromultimers and uses thereof

ARTIFICIAL RECEPTORS, RECOMBINANT CELLS COMPRISING THEREOF, METHODS FOR THEIR PREPARATION, AND METHOD OF USING THEREOF

Protease-resistant systems for polypeptide display and methods of making and using thereof

NOVEL ADP-RIBOSYL CYCLASE AND INHIBITOR THEREOF

MINIGENE THERAPY

METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS

TIGIT- AND LIGHT-BASED CHIMERIC PROTEINS

SYNTHETIC COMPOUND

SYNTHETIC PRODUCTION OF SINGLE-STRANDED ADENO ASSOCIATED VIRAL DNA VECTORS

METHOD AND SYSTEM FOR PREDICTING COUPLING PROBABILITIES OF G-PROTEIN COUPLED RECEPTORS WITH G-PROTEINS

Modular Therapeutics for the Treatment of Inflammatory Diseases and Cancer

GABA AGONISTS AND ANTAGONISTS AFFECT DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS AND MEGAKARYOCYTE PROGENITORS

Bruton's Tyrosine Kinase as Anti-Cancer Drug Target

Epitope specific to SMO protein, antibody recognizing same, and composition comprising same

METHODS OF TREATING CANCER

THERAPEUTIC PEPTIDES

GENE THERAPIES FOR LYSOSOMAL DISORDERS

VIRUS COLLECTION MATRIX

CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19

Reporting construct with synaptobrevin based moiety

Anti-AQP4 antibodies

GENE THERAPY FOR TREATING OR PREVENTING VISUAL EFFECTS IN BATTEN DISEASE

RECOMBINANT AAV-CRUMBS HOMOLOGUE COMPOSITION AND METHODS FOR TREATING LCA-8 AND PROGRESSIVE RP

METHODS FOR IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF METABOLIC DISORDERS USING SLIT2

DNA-BINDING DOMAIN TRANSACTIVATORS AND USES THEREOF

METHODS AND COMPOSITIONS FOR TREATING CANCER

HIGHLY FUNCTIONAL MANUFACTURED ABCB5+ MESENCHYMAL STEM CELLS

Functional peptides having antimicrobial activity against phytopathogenic microorganisms

GENE THERAPIES FOR STARGARDT DISEASE (ABCA4)

ENHANCED HUMAN OPSIN PROMOTER FOR ROD SPECIFIC EXPRESSION

EVASINS FOR USE IN THERAPY AND DIAGNOSTICS

Chloride salt of TAT-NR2B9C

COMPOSITIONS AND METHODS FOR BIOSYNTHESIS OF TERPENOIDS OR CANNABINOIDS IN A HETEROLOGOUS SYSTEM

Compositions and methods for regulating production of a precursor protein

COMPOSITIONS AND METHODS FOR REGULATING PRODUCTION OF A PRECURSOR PROTEIN

Tagged chimeric effector molecules and receptors thereof

Screening Assays, Modulators and Modulation of Intracellular Signalling Mediated by Immunoglobulin Superfamily Cell Adhesion Molecules

NLRP3 INFLAMMASOME INHIBITION

NUCLEIC ACID CONSTRUCT ENCODING Trk FRAGMENT AND USE THEREOF

MULTIMERS

Configuring a smart home controller

ROR1 ANTIBODY COMPOSITIONS AND RELATED METHODS

CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19

A Novel Prostate Apoptosis Response-4 (Par-4) Protein Entity with an Extended Duration of Action for Therapeutic Treatment of Cancer

METHODS FOR CONTROLLED ACTIVATION OR ELIMINATION OF THERAPEUTIC CELLS

VACCINE COMPOSITIONS COMPRISING AN AMPHIPATHIC COMPOUND, A NEOANTIGEN AND A HYDROPHOBIC CARRIER, AND METHODS OF USE THEREOF

CD1a antibody-expressing CAR T-cells for the treatment of CD1a-positive cancer

COMPOSITIONS AND METHODS FOR SELECTIVE GENE REGULATION

suPAR and Prediction and Treatment of Acute Kidney Injury

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Notch receptors with hinge domain

SYNP5 (PROA9), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN RETINAL GANGLION CELLS

Recombinant adeno associated virus encoding clarin-1 and uses thereof

PAR4 DERIVED PEPTIDES, ANALOGS AND USES THEREOF

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Light-responsive polypeptides and methods of use thereof

CANCER THERAPY BY MODIFYING NEOANTIGEN EXPRESSION

Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Amidated peptides and their deamidated counterparts displayed by HLA-A*02 for use in immunotherapy against different types of cancers

Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof

Disease-associated antigens and methods of use thereof

COMPOSITION FOR DELIVERY OF GENETIC MATERIAL

Engineered PD-1 variants

EXTRACELLULAR VESICLE COMPRISING A FUSION PROTEIN HAVING FC BINDING CAPACITY

mRNA combination therapy for the treatment of cancer

Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells

RECOMBINANT ADENO-ASSOCIATED VIRAL VECTOR FOR GENE DELIVERY

SYNP66 (PROA21), A PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN RETINAL GANGLION CELLS

Gene Therapy for BEST1 Dominant Mutations

PROTEINS AND FLUOROPHORE-CONTAINING COMPOUNDS SELECTIVE FOR NaV1.7

Systemic delivery of adeno-associated virus vector expressing gamma-sarcoglycan and the treatment of muscular dystrophy

Therapeutic Cell Systems and Methods for Treating Cancer and Infectious Diseases

CANCER ANTIGEN TARGETS AND USES THEREOF

MULTIMERIC CODING NUCLEIC ACID AND USES THEREOF

Methods for epitope selection

GPR156 Variants And Uses Thereof

Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Autoimmune Indications

Treatment of cancer using humanized anti-BCMA chimeric antigen receptor

Engineered extracellular receptor constructs and uses thereof

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

MOLECULAR SIGNATURE OF CANCER

Drug-controlled systems and uses thereof

CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF

IMMUNE EFFECTOR CELL TARGETING GPC3 AND APPLICATION THEREOF

COMPOSITIONS AND METHODS FOR USE OF RED-SHIFTED ANION CHANNEL RHODOPSINS

MODIFIED MRNA FOR THE TREATMENT OF PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS DISORDERS

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Cell Body Targeted Sensors

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

SALMONELLA VACCINE FOR THE TREATMENT OF CORONAVIRUS

REGULATABLE CELL SURFACE RECEPTORS AND RELATED COMPOSITIONS AND METHODS

ENGINEERED T-CELL MODULATING MOLECULES AND METHODS OF USING SAME

Engineered platelets for targeted delivery of a therapeutic agent

Neuropilin-1 Specific Binding Peptide, Fusion Protein Fused with Same, and Use Thereof

TLR9-TARGETED THERAPEUTICS

MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE

AAV-MEDIATED SUBCELLULAR TARGETING OF HETEROLOGOUS RHODOPSINS IN RETINAL GANGLION CELLS

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Breast and ovarian cancer vaccines

CHIMERIC NUCLEIC ACID MOLECULES WITH NON-AUG TRANSLATION INITIATION SEQUENCES AND USES THEREOF

ADENO-ASSOCIATED VIRAL VECTORS FOR THE TREATMENT OF BEST DISEASE

METHODS OF MAKING PLATELETS COMPRISING MODIFIED RECEPTORS AND USES THEREOF

Composition comprising recombinant GPlbα receptor protein

CHIMERIC ANTIGEN RECEPTORS COMPRISING BCMA-SPECIFIC FIBRONECTIN TYPE III DOMAINS AND USES THEREOF

Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

Polypeptide and method of producing IMP using the same

LPL-GPIHBP1 FUSION POLYPEPTIDES

Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

Pharmaceutical compositions and methods targeting Wnt pathway proteins

A METHOD OF DETERMINING RISK FOR SKIN CANCER DEVELOPMENT AND SKIN CANCER THERAPEUTIC PREVENTION BY MEASURING PD-1/PD-L1 SIGNALING PATHWAY MEMBERS

Peptide

Protein-based purification matrices and methods of using the same

MULTIPLE VECTOR SYSTEM AND USES THEREOF

SURROGATE CO-RECEPTORS FOR T CELLS AND METHODS OF USE

CRY2 variant having increased photosensitivity and use thereof

METHODS AND COMPOSITIONS FOR TREATING ACTIVATED G-ALPHA Q MUTANT CANCERS OR MELANOCYTIC MALIGNANCIES

Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibody

COMPOUNDS AND COMPOSITIONS THAT INHIBIT OR PREVENT LIPOPROTEIN ENTRY INTO THE ENDOTHELIUM

TMEM100 PEPTIDES AND VARIANTS THEREOF AND THEIR USE IN TREATING OR PREVENTING DISEASES OR CONDITIONS

MODIFIED LIGAND-GATED ION CHANNELS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS

ANTI-TAU CONSTRUCTS

BISPECIFIC FAB FUSION PROTEINS COMPRISING A CD3-BINDING FAB FRAGMENT WITH N-TERMINAL FUSION TO A BINDING DOMAIN AND METHODS OF USE

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

Personalized immunotherapy against several neuronal and brain tumors

COMPOSITIONS AND METHODS FOR TREATMENT OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

EXTRACELLULAR VESICLES FOR REPLACEMENT OF UREA CYCLE PROTEINS & NUCLEIC ACIDS

Extracellular vesicles comprising engineered fusion proteins

PEPTIDE-RECEPTIVE MHC-I COMPLEX COMPOSITIONS AND METHODS

Artificial synapses

Use of the CD2 signaling domain in second-generation chimeric antigen receptors

Chimeric antigen receptor with a spacer comprising C2-set Ig-like domains

Personalized immunotherapy against several neuronal and brain tumors

MODIFIED MEMBRANE SPANNING PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF

Transmembrane polypeptides

Methods Of Cell Selection

CONDITIONALLY ACTIVE CHIMERIC ANTIGEN RECEPTORS FOR MODIFIED T-CELLS

Peptides and combination of peptides for use in immunotherapy against various cancers

KIR 7.1 GENE THERAPY VECTORS AND METHODS OF USING THE SAME

ADENO-ASSOCIATED VIRUS (AAV) SEROTYPE 8 SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR

NOVEL MEANS TO MODULATE NMDA RECEPTOR-MEDIATED TOXICITY

Compositions and methods for switchable CAR T cells using surface-bound sortase transpeptidase

COMPOSITIONS AND METHODS OF USE OF IL-10 AGENTS IN CONJUNCTION WITH CHIMERIC ANTIGEN RECEPTOR CELL THERAPY

MODIFIED CHANNEL RHODOPSIN

Modified peptide fragments of CAV-1 protein and the use thereof in the treatment of fibrosis

Peptides and combination of peptides for use in immunotherapy against various cancers

Breast and ovarian cancer vaccines

Sequencing method for CAR T cell therapy

METHOD FOR TREATING GLIOBLASTOMA

INTERLEUKIN-13 RECEPTOR ALPHA 2 PEPTIDE-BASED BRAIN CANCER VACCINES

Ligand Matched Transcription Control, Control Devices, and Solute Carriers

NUCLEIC ACID CONSTRUCTS COMPRISING GENE EDITING MULTI-SITES AND USES THEREOF

Affinity matured CD22-specific monoclonal antibody and uses thereof

Antivirus proteins having a Kringle 5 subunit

MODIFIED T CELLS AND METHODS OF THEIR USE

COMPOSITIONS AND METHODS FOR TREATING PATIENTS WITH RTK MUTANT CELLS

PRECISELY ENGINEERED STEALTHY MESSENGER RNAS AND OTHER POLYNUCLEOTIDES

Tropomyosin receptor kinase (TRK) degradation compounds and methods of use

Anti-bril antibody

Use of epithelial membrane protein 2 [EMP2] targeting agents in treating lung disorders

REDIRECTED CELLS WITH MHC CHIMERIC RECEPTORS AND METHODS OF USE IN IMMUNOTHERAPY

GENE THERAPY METHODS TO CONTROL ORGAN FUNCTION

ANIMAL CELL, METHOD FOR PRODUCING ANIMAL CELL, AND METHOD FOR PRODUCING TARGET PROTEIN

BI-SPECIFIC FUSION PROTEINS FOR DEPLETION OF REGULATORY T CELLS

ANTIBODY THAT BINDS MURINE WISE PROTEIN

REGULATORY T CELL EPITOPES

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE

ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR

IMPLANTS FOR RECRUITING AND REMOVING CIRCULATING TUMOR CELLS

COMPOSITIONS FOR DETECTING SECRETION AND METHODS OF USE

METHOD FOR PRODUCING NATURAL KILLER CELLS FROM PLURIPOTENT STEM CELLS

Peptides and combination of peptides for use in immunotherapy against various cancers

Peptides and combination of peptides for use in immunotherapy against various cancers

ENGINEERED HEMICHANNELS, ENGINEERED VESICLES, AND USES THEREOF

GENE THERAPY FOR TREATING FAMILIAL HYPERCHOLESTEROLEMIA

METHODS OF PROMOTING CNS NEURONAL REPAIR BY INHIBITING LRP-1

Encryption device and operation method thereof

Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders

Peptides and combination of peptides for use in immunotherapy against various cancers

Methods and composition for gene delivery using an engineered viral particle

Methods of treating cholangiocarcinoma

BIOPHARMACEUTICAL AGENTS FOR USE IN REDUCING LIPID CONTENT IN CELLS

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

USE OF A CAR CELL HAVING CROSSLINKED DISULFIDE BRIDGE ON ANTIGEN RECOGNIZING MOIETY FOR TARGETTING CANCER CELLS

PROMOTER FOR THE SPECIFIC EXPRESSION OF GENES IN MÜLLER CELLS

COMPOSITIONS AND METHODS FOR REGULATING MYELINATION

Anti-TrkB agonist antibodies binding to D1 domain of TrkB

HEPATITIS B AND/OR HEPATITIS D-PERMISSIVE CELLS AND ANIMALS

MALARIA VACCINE AND METHODS FOR PRODUCING SAME

Notch receptors with hinge domain

METHODS OF ACTIVATING REGULATORY T CELLS

USE OF AN ANTI-CD2 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENEIC CELL THERAPY

Methods for detection of botulinum neurotoxin

RECOMBINANT NERVOUS SYSTEM CELLS AND METHODS TO GENERATE THEM

Modified immunoglobulin hinge regions to reduce hemagglutination

BIVALENT CHIMERIC ENGULFMENT RECEPTORS AND USES THEREOF

TLR9 ligand trap

METHOD OF PRODUCING CAR-T CELLS, NUCLEIC ACID-INTRODUCING CARRIER AND KIT

Methods for improving the efficacy and expansion of immune cells

Astrotactin1-based compositions and pharmaceutical formulations

Receptors for ligand-dependent transcriptional regulation

Inverted transporter polypeptides and methods of using

BIO-IMAGING PROBES AND METHODS FOR NON-INVASIVE DETECTION OF HUMAN UTERINE SARCOMAS

Cellular receptors and uses thereof

Glucose transporter 4 antibodies, methods of making the same, and uses thereof

MODIFIED MITOCHONDRIA AND USE THEREOF

Engineering Extracellular Vesicles for Affinity Purification

Solute Carrier Family 14 Member 1 (SLC14A1) Variants And Uses Thereof

Neutralizing antibodies to the alpha v beta 8 integrin complex for immunotherapy

Personalized immunotherapy against several neuronal and brain tumors

Antibody against human DLK1 and use thereof

Recombinant CDHR3 protein fragments inhibit rhinovirus C binding and replication

Sonogenic stimulation of cells

COMPOSITIONS AND METHODS FOR INDUCING SCARRING BY PERI-TUMORAL CELLS

PEPTIDE VACCINE THERAPY FOR TREATMENT OF FRa-EXPRESSING TUMORS

Drug-Resistant Immune Cells and Methods of Use Thereof

Transgenic macrophages, chimeric antigen receptors, and associated methods

Antigen-binding chimeric proteins and methods and uses thereof

EGFR and C-met fibronectin type III domain binding molecules

Fusion proteins comprising an engineered knottin peptide and uses thereof

CYTOKINE FUSION POLYPEPTIDE AND CYTOKINE LIBRARY COMPRISING SAME

Methods to create chemically-induced dimerizing protein systems for regulation of cellular events

COMPOSITIONS AND METHODS FOR INCREASING BEIGING OF WHITE ADIPOSE TISSUE

Neuropilin-1 Specific Binding Peptides and its Fusion Protein, and Use Thereof

EphA2 T-cell epitope agonists and uses therefore

CHIMERIC ANTIGEN RECEPTOR AND METHODS OF USE THEREOF

Methods and compositions for treating and protecting against porcine reproductive and respiratory syndrome virus

ANTIMALARIAL DRUG, MALARIA TREATMENT METHOD, SCREENING METHOD FOR CANDIDATE SUBSTANCE FOR MALARIA TREATMENT, MALARIA SEVERITY MARKER, METHOD FOR TESTING RISK OF SEVERE MALARIA, AND TEST REAGENT

CELL SORTING SYSTEMS AND METHODS OF USE

THERAPEUTIC REGIMENS FOR CHIMERIC ANTIGEN RECEPTOR (CAR)- EXPRESSING CELLS

CHIMERIC ANTIGEN RECEPTOR FIBROBLAST CELLS FOR TREATMENT OF CANCER

ADENO-ASSOCIATED VIRUS (AAV) CLADES, SEQUENCES, VECTORS CONTAINING SAME, AND USES THEREFOR

CS1 targeted chimeric antigen receptor-modified T cells

Use of toll-like receptor agonist for treating cancer

CONTROL AND MODULATION OF THE FUNCTION OF GENE-MODIFIED CHIMERIC ANTIGEN RECEPTOR T CELLS WITH DASATINIB AND OTHER TYROSINE KINASE INHIBITORS

Intercellular proximity labeling using eGRASP

ASGR INHIBITORS

PD-L1 BINDING AFFIMERS, AND USES RELATED THERETO

Antibodies specific for sulfation sites of Wnt pathway proteins

Engineered cells, T cell immune modulating antibodies and methods for using the same

ALK4:ActRIIB heteromultimers and uses thereof

Methods of treating lysosomal disorders

Mouse having a humanized cluster of differentiation 47 gene

Trans-splicing molecules

Use of gene editing to generate universal TCR re-directed t cells for adoptive immunotherapy

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST NHL AND OTHER CANCERS

METHODS FOR SCREENING FOR BINDING PARTNERS OF G-PROTEIN COUPLED RECEPTORS

Artificially manipulated immune cell

PROCESS FOR PRODUCING A MEMBRANE PROTEIN

Oncolytic viruses for sensitizing tumor cells to killing by natural killer cells

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THEREOF

METHOD FOR THE IN VITRO DIFFERENTIATION AND MATURATION OF DENDRITIC CELLS FOR THERAPEUTIC USE

CHIMERIC NOTCH RECEPTORS

Biomarkers for Diagnosis and Prognosis of Corneal Ectatic Disorders

Methods of assessing or monitoring a response to a cell therapy

RANKL-specific agent for treating metastatic disease

AAV TRANSFER CASSETTE

CMV VECTORS AND USES THEREOF

PEPTIDES DERIVED FROM SOLUTE CARRIER FAMILY 45 MEMBER 2 (SLC45A2) AND USES THEREOF

SPHERICAL NUCLEIC ACIDS WITH DENDRITIC LIGANDS

IMMUNE CELL TREATMENT OF NERVE DAMAGE

Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and infectious disease

Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof

ACTRIIB ANTAGONISTS AND DOSING AND USES THEREOF

Extracellular vesicles and methods of using

BINDING-TRIGGERED TRANSCRIPTIONAL SWITCHES AND METHODS OF USE THEREOF

Hinge area and use of same in constructing car skeleton

Methods of treatment and novel constructs

NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS

Method for promoting proliferation of immune cells

Human tissue stem cell and use thereof

GENE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES

Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids

METHODS FOR CELL-TYPE SPECIFIC PROFILING TO IDENTIFY DRUG TARGETS

Therapeutic agents

REGULATABLE CHIMERIC ANTIGEN RECEPTOR

Chimeric TIM4 receptors and uses thereof

TLR9 inhibitors to suppress inflammatory response to pathogens

Therapeutical tools and methods for treating blindness by targeting photoreceptors

Methods for simultaneous measurement of multiple biological signals from spectrally identical fluorescent reporters

AAV vectors encoding clarin-1 or GJB2 and uses thereof

Peptide hydrogels and use thereof

COMPOSITIONS AND METHOD FOR REDUCING SEIZURES

IN VIVO PRODUCTION OF PROTEINS